An RNA:DNA “sandwich” plays a key role in behavioral adaptations arising from emotional experiences
Peer-Reviewed Publication
Latest funded news by National Institute on Drug Abuse (NIDA)
Updates every hour. Last Updated: 7-May-2025 04:09 ET (7-May-2025 08:09 GMT/UTC)
Neuroscience researchers at the Medical University of South Carolina report in Science that special genetic structures, known as R-loops, control the expression of a key gene important for responding to emotional experiences. This genetic mechanism may be particularly important for guiding maladaptive behavioral responses related to psychiatric disorders like substance use and mood disorders.
New research from University of Pennsylvania psychologist Joe Kable looks at individuals with damage to different parts of the prefrontal cortex to reveal how the brain evaluates uncertainty and guides split-second decisions.
Researchers at the NYU Pain Research Center have found a new receptor for nerve growth factor that plays an important role in pain signaling, even though it does not signal on its own, according to a study published in the Journal of Clinical Investigation. The findings hold promise for finding new treatments for arthritis and other forms of inflammatory and cancer pain, without the side effects that led recent therapies to fail in clinical trials.
Brain-wide association studies, which use magnetic resonance imaging to identify relationships between brain structure or function and human behavior or health, have faced criticism for producing results that often cannot be replicated by other researchers. A new study published in Nature offers practical guidance for scientists designing future brain imaging studies, potentially helping them obtain reliable results with fewer participants.
New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug use.
Substance use disorders are notoriously difficult to treat, as it is challenging to intervene in a drugs’ effect on the brain’s reward pathway without interfering with the pathway’s normal function. In a University of Arizona Health Sciences study, researchers identified a drug that reduced the desire for cocaine in a murine model while keeping the brain’s reward pathways for sugar intact.